Adicet Bio, Inc.
Symbole: ACET
NASDAQ
1.69
USDPrix du marché aujourd'hui
-0.5143
Ratio P/E
0.0002
Ratio PEG
138.87M
Cap MRK
- 0.00%
Rendement DIV
Adicet Bio, Inc. (ACET) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 780.07 | 159.7 | 257.7 | 277.5 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 1.23 | 0 | 0.4 | 0.2 | ||||||||||||||||
balance-sheet.row.inventory | 6.39 | 0 | 2.6 | 4.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 3.94 | 2.6 | 0.4 | 0 | ||||||||||||||||
balance-sheet.row.total-current-assets | 791.62 | 162.3 | 261 | 282.4 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 188.76 | 44.2 | 49 | 35 | ||||||||||||||||
balance-sheet.row.goodwill | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | -0.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.85 | 0.8 | 1.2 | 2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 231.54 | 45 | 69.7 | 56.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1023.16 | 207.3 | 330.7 | 338.9 | ||||||||||||||||
balance-sheet.row.account-payables | 12.56 | 2.6 | 4.4 | 3.3 | ||||||||||||||||
balance-sheet.row.short-term-debt | 12.34 | 3.2 | 2.5 | 1.6 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 76.52 | 17.7 | 18.5 | 19.4 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 51.09 | 13.4 | 12.8 | 6.7 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 77.04 | 17.8 | 18.6 | 19.5 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 85.64 | 17.7 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.total-liab | 153.03 | 37.1 | 38.4 | 35.8 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 338.9 | ||||||||||||||||
balance-sheet.row.common-stock | 0.02 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -1302.45 | -380.8 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | -338.9 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1637.35 | 550.9 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 487.95 | 207.3 | -199.8 | -132.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 487.95 | - | - | - | ||||||||||||||||
Total Investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.total-debt | 88.86 | 20.9 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.net-debt | -691.21 | -138.8 | -236.6 | -256.6 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.66 | -142.7 | -69.8 | -62 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.1 | 6.1 | 2.6 | 1.5 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 9.71 | -34.1 | 0 | 1.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 20.26 | 20.3 | 17.1 | 12.5 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0.25 | 0.3 | 2.7 | -6.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0.2 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 2 | ||||||||||||||||
cash-flows.row.account-payables | -1.68 | -1.7 | 1.7 | 1.1 | ||||||||||||||||
cash-flows.row.other-working-capital | 1.94 | 1.9 | 0.8 | -9.2 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 12.62 | 56.5 | 2.6 | 1.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -93.72 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 10.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4.46 | -4.5 | -16.8 | -2.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.39 | 0.4 | 43.4 | 238.1 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.15 | -0.1 | -3.2 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0.08 | -0.1 | -1.9 | 4.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.24 | 0.2 | 41.5 | 242.7 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -97.94 | -97.9 | -20 | 188.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 780.07 | 159.7 | 257.7 | 277.7 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 878.01 | 257.7 | 277.7 | 88.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -93.72 | -93.7 | -44.8 | -51.1 | ||||||||||||||||
cash-flows.row.capital-expenditure | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.free-cash-flow | -98.18 | -98.2 | -61.5 | -64.1 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 25 | 9.7 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 8.14 | 6.1 | 5 | 0 | ||||||||||||||||
income-statement-row.row.gross-profit | -8.14 | -6.1 | 20 | 9.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 106.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.53 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.operating-expenses | 130.89 | 126.5 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 132.58 | 132.6 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.interest-income | 9.98 | 10 | 3.8 | 0.1 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 7.3 | 6.1 | 2.8 | -0.5 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -120.41 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -152.04 | -132.6 | -72.6 | -61.4 | ||||||||||||||||
income-statement-row.row.income-before-tax | -142.66 | -142.7 | -69.8 | -62.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.51 | 0 | -2.8 | -0.1 | ||||||||||||||||
income-statement-row.row.net-income | -141.4 | -142.7 | -67 | -62 |
Questions fréquemment posées
Quel est le total de Adicet Bio, Inc. (ACET) de l'actif total?
Adicet Bio, Inc. (ACET) Le total des actifs est 207295000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.000.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -2.281.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.000.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.000.
Qu'est-ce que Adicet Bio, Inc. (ACET) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -142658000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 20924000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 126478000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 159711000.000.